Logo
x

Search

Subscribe Now

 Janssen

Essential Pharma Acquires Reminyl (galantamine hydrobromide) Oral Capsules from Janssen

Essential Pharma Acquires Reminyl (galantamine hydrobromide) Oral Capsules from Janssen

  • April 18, 2024
Insights+: EMA Marketing Authorization of New Drugs in February 2024

Insights+: EMA Marketing Authorization of New Drugs in February 2024

  • March 20, 2024
Insights+: EMA Marketing Authorization of New Drugs in December 2023

Insights+: EMA Marketing Authorization of New Drugs in December 2023

  • January 23, 2024
PharmaShots Weekly Snapshots (December 18 – December 22, 2023)

PharmaShots Weekly Snapshots (December 18 – December 22, 2023)

  • December 25, 2023
Vanda Pharmaceuticals to Acquire the US and Canadian Rights for Ponvory from Actelion to Treat Relapsing Multiple Sclerosis

Vanda Pharmaceuticals to Acquire the US and Canadian Rights for Ponvory from Actelion to Treat Relapsing Multiple Sclerosis

  • December 8, 2023
Arrowhead and Janssen Entered into a Licensing Agreement with GSK for JNJ-3989 to Treat Chronic Hepatitis B

Arrowhead and Janssen Entered into a Licensing Agreement with GSK for JNJ-3989 to Treat Chronic Hepatitis B

  • November 1, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.